Darling Ingredients’ health brand Rousselot receives Brazilian Patent for gelatin technology that improves production of nutraceutical gummies

Darling Ingredients’ health brand Rousselot, announced today that the Brazilian Patent Office has granted it Patent No. BR 11 2019 014789 6, securing Rousselot’s intellectual property rights for SiMoGel™, a specialized gelatin technology that eliminates the need for starch-based gummy production.

 

SiMoGel allows for the production of nutraceutical gummies using silicon or metal molds, which are easily cleanable and eliminate dust during production, unlike traditional starch trays. SiMoGel also significantly reduces setting time to less than 30 minutes, compared to 24 hours for conventional starch-based production. 

 

Rousselot previously received patents for SiMoGel from the U.S. Patent and Trademark Office (USPTO) in November of 2022 and the European Patent Office (EPO), for all major European countries, in November of 2021.

 

“SiMoGel is a remarkable technology for streamlining the production of  functional gummies in a highly hygienic environment,” said Pierre-Albert Thomas, Director of Rousselot Functional Ingredients. “This Brazilian patent reaffirms Rousselot’s leadership in innovation and demonstrates our commitment to offering customers new and improved gelatin-based formulations.”

 

Between 2018 and 2022, Innova Market Insights reported a 46.4% Compound Annual Growth Rate (CAGR) in the launch of nutraceutical gummies, while Future Market Insights anticipates a robust 13.4% CAGR in the nutraceutical gummy market from 2023 to 2033.